Matches in Wikidata for { <http://www.wikidata.org/entity/Q89613604> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q89613604 description "article scientifique publié en 2020" @default.
- Q89613604 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89613604 description "scientific article published on 08 February 2020" @default.
- Q89613604 description "wetenschappelijk artikel" @default.
- Q89613604 description "наукова стаття, опублікована 8 лютого 2020" @default.
- Q89613604 name "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 name "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 type Item @default.
- Q89613604 label "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 label "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 prefLabel "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 prefLabel "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 P1433 Q89613604-267774F7-B6C8-416C-9B60-0ED751C6DF05 @default.
- Q89613604 P1476 Q89613604-1FE57CBF-D9E6-4077-A579-33E129C00549 @default.
- Q89613604 P2093 Q89613604-1172C3BC-F066-4810-A459-0E309B6D2C03 @default.
- Q89613604 P2093 Q89613604-250C2313-9A42-46EA-8694-71363EAC7D17 @default.
- Q89613604 P2093 Q89613604-2CE9E14B-54F9-45CE-974B-28EC6A9FA688 @default.
- Q89613604 P2093 Q89613604-52FFE237-231A-40EA-825B-D60E4DEE1E1D @default.
- Q89613604 P2093 Q89613604-7AEEA92B-C8FF-4879-84BE-E3A4F7456AB8 @default.
- Q89613604 P2093 Q89613604-87BF78B2-4E03-40BE-A2AA-3F466BB2C9E4 @default.
- Q89613604 P304 Q89613604-949E4BFD-E86B-40FA-933C-6AEA313B7B64 @default.
- Q89613604 P31 Q89613604-684A963B-018A-4D72-B123-4C4CF0C5B9E4 @default.
- Q89613604 P356 Q89613604-816BD8B0-6B67-4F6D-BE05-39F746CEEE3C @default.
- Q89613604 P577 Q89613604-59BEF651-7FDD-46C2-A07D-6F1568D610B9 @default.
- Q89613604 P698 Q89613604-67213510-00CD-4DD0-8059-102F40E783F4 @default.
- Q89613604 P356 10428194.2020.1723012 @default.
- Q89613604 P698 32036719 @default.
- Q89613604 P1433 Q6534493 @default.
- Q89613604 P1476 "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'" @default.
- Q89613604 P2093 "Craig C Earle" @default.
- Q89613604 P2093 "Lee Mozessohn" @default.
- Q89613604 P2093 "Matthew C Cheung" @default.
- Q89613604 P2093 "Nicole Mittmann" @default.
- Q89613604 P2093 "Ning Liu" @default.
- Q89613604 P2093 "Rena Buckstein" @default.
- Q89613604 P304 "1-10" @default.
- Q89613604 P31 Q13442814 @default.
- Q89613604 P356 "10.1080/10428194.2020.1723012" @default.
- Q89613604 P577 "2020-02-08T00:00:00Z" @default.
- Q89613604 P698 "32036719" @default.